tiprankstipranks
Trending News
More News >
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market

Piramal Pharma Limited (PPLPHARMA) Financial Statements

Compare
10 Followers

Piramal Pharma Limited Financial Overview

Piramal Pharma Limited's market cap is currently ₹224.11B. The company's EPS TTM is ₹-0.7; its P/E ratio is -925.86; and it has a dividend yield of 0.08%. Piramal Pharma Limited is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 91.51B₹ 81.71B₹ 70.82B₹ 65.59B₹ 58.87B
Gross Profit₹ 59.20B₹ 49.09B₹ 10.98B₹ 13.80B₹ 38.13B
Operating Income₹ 36.12B₹ 5.20B₹ -359.80M₹ 3.74B₹ 22.46B
EBITDA₹ 14.04B₹ 13.67B₹ 8.46B₹ 12.60B₹ 12.97B
Net Income₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Balance Sheet
Cash & Short-Term Investments₹ 5.21B₹ 5.02B₹ 6.60B₹ 3.79B₹ 1.62B
Total Assets₹ 156.78B₹ 153.12B₹ 145.23B₹ 127.97B₹ 57.57B
Total Debt₹ 48.56B₹ 47.10B₹ 56.37B₹ 41.28B₹ 1.74B
Net Debt₹ 43.55B₹ 43.53B₹ 54.41B₹ 39.00B₹ 275.30M
Total Liabilities₹ 75.52B₹ 74.00B₹ 77.49B₹ 61.00B₹ 16.56B
Stockholders' Equity₹ 81.25B₹ 79.11B₹ 67.73B₹ 66.97B₹ 41.01B
Cash Flow
Free Cash Flow₹ 2.28B₹ 2.92B₹ -4.81B₹ -1.23B₹ -233.90M
Operating Cash Flow₹ 8.92B₹ 10.05B₹ 4.84B₹ 7.66B₹ 347.20M
Investing Cash Flow₹ -4.77B₹ -4.34B₹ -13.39B₹ -18.12B₹ -43.83B
Financing Cash Flow₹ -4.41B₹ -4.22B₹ 8.18B₹ 7.94B₹ 44.94B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History

Piramal Pharma Limited Debt to Assets

Piramal Pharma Limited Cash Flow

Piramal Pharma Limited Forecast EPS vs Actual EPS